Developer docs
API playgroundTry for free, no card

Search company profiles

PulseNmore

Full company profile

uuid0000zbf

Namestring
PulseNmore
Legal namestring
Pulsenmore Ltd.
Websiteurl
pulsenmore.com
Company typeenum
Public
Founded yearint
2014
Descriptiontext

PulseNmore Ltd. is an Israel-based digital health company (publicly listed on Nasdaq and TASE under PLSM) that develops connected home ultrasound technology for prenatal and fertility care. Its platform combines a handheld ultrasound transducer cradle (260g, B-mode and M-mode at 2-5 MHz, up to 27cm depth, 1080p resolution) that connects to the patient's personal smartphone, a patient-facing mobile application (iOS and Android) supporting both app-guided and real-time clinician-guided teleultrasound workflows, and a web-based clinician dashboard with EMR integration. The company markets two core products: Pulsenmore ES, an FDA De Novo-authorized home-use prenatal ultrasound platform for fetal well-being assessment from week 14 of pregnancy, and Pulsenmore FC, an at-home follicular monitoring solution for IVF and fertility preservation cycles.

PulseNmore serves expectant mothers, fertility/IVF patients, obstetricians, maternal-fetal medicine specialists, and health systems, with named anchor customers including Clalit Health Services (Israel's largest HMO, ~5 million members), Sheba Medical Center's Sheba Beyond virtual hospital, Beilinson NEXT virtual hospital, Ouma Health (U.S. virtual maternity care), and U.S. practices TLC Perinatal PA and the Center for Fetal Medicine & Women's Ultrasound. Revenue is generated through a combination of hardware device sales (single-patient, one-pregnancy use cradle), subscription/recurring service contracts (e.g., $4.5M five-year Clalit FC agreement, 25,000-unit Clalit ES supply commitment), and strategic partnership economics anchored by GE Healthcare's $50 million investment with distribution rights. Distribution combines direct enterprise sales to health systems and providers, a consumer-facing shop.pulsenmore.com storefront requiring physician prescription, and channel partners/distributors across the U.S., EU, UK, Switzerland, Australia, Brazil, Colombia, and Israel.

Short descriptiontext

PulseNmore is an Israel-based digital health company developing FDA-authorized connected home ultrasound devices for prenatal and IVF monitoring, serving expectant mothers, fertility patients, obstetricians, and health systems via a smartphone-connected handheld cradle, mobile app, and clinician dashboard.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersRamat Gan, Israel
HQ citystring
Ramat Gan
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
home ultrasound devices, prenatal care platform, connected medical imaging, remote fetal monitoring, telemedicine ultrasound
Industry5 codes
PRIMARYHLALAHAC
Pregnancy & Prenatal Care Telehealth (OB tele-visits, prenatal monitoring)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)
SECONDARYHLACAFAC
Maternal & Neonatal Remote Monitoring Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLAHACAF
Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAG
Maternal, Neonatal & Pediatric Remote Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAHABAD
Ultrasound & Echography Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Home Health Care Services62161
  • Diagnostic Imaging Centers621512
SIC code2 codes
  • Electromedical & Electrotherapeutic Apparatus3845
  • Surgical & Medical Instruments & Apparatus3841
Product category
Home Prenatal Ultrasound Devices
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Hardware Device Sales
TypeHardware Sales
Description

Sale of Pulsenmore ES home ultrasound devices. Single patient, one pregnancy use device.

stocktitan.net
2Subscription/Service Platform
TypeSubscription Recurring
Description

Ongoing service fees for cloud platform access, clinician dashboard, scan interpretation services, and technical support. $4.5M contract with Clalit over 5 years for Pulsenmore FC follicular monitoring service.

pulsenmore.com
3Strategic Investment
TypeLicensing Royalties
Description

GE Healthcare invested $50 million to support product approval and market expansion, including distribution rights in key markets.

163.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Pricing details2 tiers
1Prescription-based device purchase through authorized providers
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Patients require prescription from healthcare provider. Device purchased from authorized Pulsenmore representatives or distributors (qualified health organizations offering remote diagnostic interpretation services).

pulsenmore.com
2Enterprise healthcare organization agreements
ModelSubscriptionBilling cadenceMulti-year contract
Notes

$4.5 million contract with Clalit Health Services over 5 years for Pulsenmore FC follicular monitoring service. 25,000 Pulsenmore ES units agreement with Clalit over 5 years.

pulsenmore.com
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Pulsenmore ES
Description

Physician-supervised home prenatal ultrasound solution for remote fetal assessment during pregnancy

pulsenmore.com
+1 more record
Core offering1 text field

PulseNmore develops and sells connected home ultrasound hardware devices that pair with a patient's smartphone via a mobile app, enabling expectant mothers to perform guided ultrasound scans at home. The company offers two core products: Pulsenmore ES for prenatal fetal well-being assessment from week 14 and Pulsenmore FC for at-home follicular monitoring in IVF and fertility preservation. Scans are transmitted to a cloud-based clinician dashboard for remote physician interpretation, with a physician-supervised model that includes both app-guided and real-time clinician-guided scanning modes.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 86.3% of surveyed users report a better pregnancy experience
+4 more records
Product overview1 text field

PulseNmore is a digital prenatal care platform providing connected home ultrasound technology. The company offers two core products: Pulsenmore ES (Early Screening) for home prenatal ultrasound monitoring and Pulsenmore FC (Follicular Monitoring) for at-home IVF and fertility monitoring. The system architecture consists of a handheld ultrasound device/cradle that attaches to the patient's smartphone, a mobile application (iOS and Android) with both app-guided and clinician-guided scanning modes, and a web-based Clinician Dashboard for remote image review and patient management. All scans are reviewed by qualified clinicians and can be documented in the patient's EMR. The platform received FDA De Novo marketing authorization in November 2025 and is deployed internationally across the U.S., Europe, Israel, Australia, and Brazil.

Product and service2 records
1Pulsenmore ES (Early Screening)
CategoryHome Prenatal Ultrasound System
Description

FDA-authorized home-use prenatal ultrasound system that includes a handheld smartphone-connected ultrasound device, a mobile application (iOS and Android), and a cloud-based clinician dashboard for remote physician interpretation. Designed for single-fetus pregnancies from week 14 onward and enables both app-guided self-scanning and real-time clinician-guided teleultrasound. Targeted at expectant mothers under physician supervision, OB-GYN and maternal-fetal medicine practices, health systems, and HMOs.

2Pulsenmore FC (Follicular Monitoring)
CategoryHome Fertility Ultrasound System
Description

At-home ultrasound solution for remote follicular monitoring in fertility care, enabling IVF and fertility preservation patients to perform transvaginal ultrasound scans at home for monitoring follicle development and endometrial thickness during treatment cycles. Deployed in partnership with fertility clinics and virtual hospitals such as Beilinson NEXT for Clalit Health Services members.

Scale indicator15 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-24
Description

Strategic partnership to integrate PulseNmore's FDA-authorized home ultrasound platform into Ouma Health's virtual maternity care model across the United States. Aims to expand remote prenatal monitoring to underserved patients and expectant mothers facing geographic barriers, including those in maternity deserts. Partnership represents significant expansion into U.S. maternal health market.

2Clalit Health Services
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-26
Description

Strategic commercial agreement with Israel's largest HMO (serving ~5 million members) for Pulsenmore FC at-home follicular monitoring for IVF and fertility preservation. Agreement potentially valued at approximately $4.5 million over five years following 18-month pilot. Service deployed via Beilinson NEXT virtual hospital. Also includes Pulsenmore ES home prenatal ultrasound with 25,000 unit agreement over 5 years.

pulsenmore.com
3Beilinson NEXT (Virtual Hospital)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-26
Description

Beilinson Medical Center's virtual hospital operating PulseNmore FC follicular monitoring service for IVF and fertility preservation patients. Enables eligible patients to perform follicular monitoring scans from home with real-time online guidance and specialist clinical oversight through Beilinson NEXT care team.

prnewswire.com
Strategic tierRegionalTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-01-01
Description

Italian medical assistance service during pregnancy designed for Italian mothers enabling remote fetal monitoring via PulseNmore. First medical assistance service of its kind in Italy, providing constant support from gynecologists, midwives, and doctors 24/7 with PulseNmore-powered remote ultrasound reviews.

5Sheba Medical Center, Tel Hashomer
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Commercial agreement for remote monitoring of high-risk pregnancies using home ultrasound solution. Sheba Medical Center utilizes PulseNmore's solution as part of its obstetrics department in 'Sheba Beyond' virtual hospital, offering medical services to insured individuals across various health funds.

pulsenmore.com
6Michigan Medicine
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Clinical trial collaboration examining ability to conduct remote biophysical profile (BPP) test using PulseNmore home ultrasound with guidance of remote clinician. Study focused on potentially reducing clinical visits while maintaining diagnostic accuracy.

pulsenmore.com
Recent move10 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Handheld, smartphone-connected ultrasound company offering a single-probe POCUS platform used across multiple clinical specialties. Directly competes with PulseNmore on portable ultrasound form factor and smartphone integration, though Butterfly is not FDA-authorized specifically for home prenatal use.

TypeBroad incumbent
Description

Global ultrasound incumbent with the Vscan Air handheld family. Also a PulseNmore investor/distributor (potential competitor-investor overlap), making it the most strategically important incumbent shaping the home/portable ultrasound category.

TypeEmerging player
Description

Developer of handheld ultrasound devices with AI-enabled workflow. Competes with PulseNmore on handheld ultrasound hardware and is pursuing POCUS use cases that overlap with PulseNmore's provider-led model.

TypeDirect peer
Description

Handheld, wireless ultrasound scanners that pair with smartphones/tablets. Closest direct comparator to PulseNmore's smartphone-cradle architecture, particularly in OB-GYN and point-of-care obstetrics use cases.

TypeBroad incumbent
Description

Philips' portable, app-based ultrasound solution for clinicians. A broad incumbent offering overlapping handheld/connected ultrasound capability, though not focused on home prenatal workflows.

TypeBroad incumbent
Description

Global medical device manufacturer with a broad portable and point-of-care ultrasound portfolio. Operates as a broad incumbent in the same hardware category as PulseNmore across multiple specialties.

TypeEmerging player
Description

Virtual maternity care platform providing remote monitoring for pregnant patients. Comparable to PulseNmore on the connected prenatal care delivery model, though focused on software/BPM rather than imaging hardware.

TypeEmerging player
Description

Virtual maternity and family care platform serving employers and health plans. Comparable as a virtual prenatal care delivery model that could partner with or compete against PulseNmore for the same telehealth maternity workflows.

TypeEmerging player
Description

Women's health and fertility device/IVF services company (part of CooperCompanies). Comparable to PulseNmore on the fertility/IVF side, particularly relevant for the Pulsenmore FC follicular monitoring product.

TypeBroad incumbent
Description

Major women's health diagnostics and medical device company with ultrasound and reproductive health offerings. Adjacent incumbent providing diagnostic women's health solutions that overlap with prenatal imaging workflows.

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks2 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

PulseNmore

Home Prenatal Ultrasound Devicespulsenmore.com

PulseNmore is an Israel-based digital health company developing FDA-authorized connected home ultrasound devices for prenatal and IVF monitoring, serving expectant mothers, fertility patients, obstetricians, and health systems via a smartphone-connected handheld cradle, mobile app, and clinician dashboard.

What PulseNmore does

PulseNmore Ltd. is an Israel-based digital health company (publicly listed on Nasdaq and TASE under PLSM) that develops connected home ultrasound technology for prenatal and fertility care. Its platform combines a handheld ultrasound transducer cradle (260g, B-mode and M-mode at 2-5 MHz, up to 27cm depth, 1080p resolution) that connects to the patient's personal smartphone, a patient-facing mobile application (iOS and Android) supporting both app-guided and real-time clinician-guided teleultrasound workflows, and a web-based clinician dashboard with EMR integration. The company markets two core products: Pulsenmore ES, an FDA De Novo-authorized home-use prenatal ultrasound platform for fetal well-being assessment from week 14 of pregnancy, and Pulsenmore FC, an at-home follicular monitoring solution for IVF and fertility preservation cycles.

PulseNmore serves expectant mothers, fertility/IVF patients, obstetricians, maternal-fetal medicine specialists, and health systems, with named anchor customers including Clalit Health Services (Israel's largest HMO, ~5 million members), Sheba Medical Center's Sheba Beyond virtual hospital, Beilinson NEXT virtual hospital, Ouma Health (U.S. virtual maternity care), and U.S. practices TLC Perinatal PA and the Center for Fetal Medicine & Women's Ultrasound. Revenue is generated through a combination of hardware device sales (single-patient, one-pregnancy use cradle), subscription/recurring service contracts (e.g., $4.5M five-year Clalit FC agreement, 25,000-unit Clalit ES supply commitment), and strategic partnership economics anchored by GE Healthcare's $50 million investment with distribution rights. Distribution combines direct enterprise sales to health systems and providers, a consumer-facing shop.pulsenmore.com storefront requiring physician prescription, and channel partners/distributors across the U.S., EU, UK, Switzerland, Australia, Brazil, Colombia, and Israel.

PulseNmore firmographics

Firmographics
Name
PulseNmore
Legal name
Pulsenmore Ltd.
Website
https://pulsenmore.com
Company type
Public
Founded year
2014
Operating status
Operating
Headcount range
51–100 employees
Short description
PulseNmore is an Israel-based digital health company developing FDA-authorized connected home ultrasound devices for prenatal and IVF monitoring, serving expectant mothers, fertility patients, obstetricians, and health systems via a smartphone-connected handheld cradle, mobile app, and clinician dashboard.
Ownership category
akta.pro rank

PulseNmore industry classification

Industry
Product category
Home Prenatal Ultrasound Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Home Health Care Services (62161), Diagnostic Imaging Centers (621512)
SIC
Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLALAHAC
Pregnancy & Prenatal Care Telehealth (OB tele-visits, prenatal monitoring)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)
SECONDARYHLACAFAC
Maternal & Neonatal Remote Monitoring Platforms
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLAHACAF
Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLACAPAG
Maternal, Neonatal & Pediatric Remote Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAHABAD
Ultrasound & Echography Systems
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

Keywords

  • Home ultrasound devices
  • Prenatal care platform
  • Connected medical imaging
  • Remote fetal monitoring
  • Telemedicine ultrasound

Where PulseNmore is headquartered

Location

Headquarters

HQ city
Ramat Gan
HQ country
Israel
HQ region
Middle East

Offices4 records

Markets served

PulseNmore business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Hardware Device Sales: Sale of Pulsenmore ES home ultrasound devices. Single patient, one pregnancy use device.
  2. Subscription/Service Platform: Ongoing service fees for cloud platform access, clinician dashboard, scan interpretation services, and technical support. $4.5M contract with Clalit over 5 years for Pulsenmore FC follicular monitoring service.
  3. Strategic Investment: GE Healthcare invested $50 million to support product approval and market expansion, including distribution rights in key markets.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goPrescription-based device purchase through authorized providers
SubscriptionMulti-year contractEnterprise healthcare organization agreements

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

PulseNmore product offering

Product offering

Core offering

PulseNmore develops and sells connected home ultrasound hardware devices that pair with a patient's smartphone via a mobile app, enabling expectant mothers to perform guided ultrasound scans at home. The company offers two core products: Pulsenmore ES for prenatal fetal well-being assessment from week 14 and Pulsenmore FC for at-home follicular monitoring in IVF and fertility preservation. Scans are transmitted to a cloud-based clinician dashboard for remote physician interpretation, with a physician-supervised model that includes both app-guided and real-time clinician-guided scanning modes.

Product overview

PulseNmore is a digital prenatal care platform providing connected home ultrasound technology. The company offers two core products: Pulsenmore ES (Early Screening) for home prenatal ultrasound monitoring and Pulsenmore FC (Follicular Monitoring) for at-home IVF and fertility monitoring. The system architecture consists of a handheld ultrasound device/cradle that attaches to the patient's smartphone, a mobile application (iOS and Android) with both app-guided and clinician-guided scanning modes, and a web-based Clinician Dashboard for remote image review and patient management. All scans are reviewed by qualified clinicians and can be documented in the patient's EMR. The platform received FDA De Novo marketing authorization in November 2025 and is deployed internationally across the U.S., Europe, Israel, Australia, and Brazil.

Differentiator

Problem solved

Functional benefit

Brands

  • Pulsenmore ES: Physician-supervised home prenatal ultrasound solution for remote fetal assessment during pregnancy
  • Pulsenmore FC

Products and services

  • Pulsenmore ES (Early Screening) FDA-authorized home-use prenatal ultrasound system that includes a handheld smartphone-connected ultrasound device, a mobile application (iOS and Android), and a cloud-based clinician dashboard for remote physician interpretation. Designed for single-fetus pregnancies from week 14 onward and enables both app-guided self-scanning and real-time clinician-guided teleultrasound. Targeted at expectant mothers under physician supervision, OB-GYN and maternal-fetal medicine practices, health systems, and HMOs.
  • Pulsenmore FC (Follicular Monitoring) At-home ultrasound solution for remote follicular monitoring in fertility care, enabling IVF and fertility preservation patients to perform transvaginal ultrasound scans at home for monitoring follicle development and endometrial thickness during treatment cycles. Deployed in partnership with fertility clinics and virtual hospitals such as Beilinson NEXT for Clalit Health Services members.

Quantifiable outcome

  • 86.3% of surveyed users report a better pregnancy experience
  • +4 more outcomes

Companies that use PulseNmore

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

PulseNmore technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

PulseNmore partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core, regional, major and strategic.

  • Ouma HealthcoreStrategic or Co-development Partner · 24 June 2026Strategic partnership to integrate PulseNmore's FDA-authorized home ultrasound platform into Ouma Health's virtual maternity care model across the United States. Aims to expand remote prenatal monitoring to underserved patients and expectant mothers facing geographic barriers, including those in maternity deserts. Partnership represents significant expansion into U.S. maternal health market.
  • Clalit Health ServicescoreStrategic or Co-development Partner · 26 January 2026Strategic commercial agreement with Israel's largest HMO (serving ~5 million members) for Pulsenmore FC at-home follicular monitoring for IVF and fertility preservation. Agreement potentially valued at approximately $4.5 million over five years following 18-month pilot. Service deployed via Beilinson NEXT virtual hospital. Also includes Pulsenmore ES home prenatal ultrasound with 25,000 unit agreement over 5 years.
  • Beilinson NEXT (Virtual Hospital)coreStrategic or Co-development Partner · 26 January 2026Beilinson Medical Center's virtual hospital operating PulseNmore FC follicular monitoring service for IVF and fertility preservation patients. Enables eligible patients to perform follicular monitoring scans from home with real-time online guidance and specialist clinical oversight through Beilinson NEXT care team.
  • Inteligea Mom to Be Medical ServiceregionalChannel Partner/ Reseller/ Distributor · 1 January 2025Italian medical assistance service during pregnancy designed for Italian mothers enabling remote fetal monitoring via PulseNmore. First medical assistance service of its kind in Italy, providing constant support from gynecologists, midwives, and doctors 24/7 with PulseNmore-powered remote ultrasound reviews.
  • Sheba Medical Center, Tel HashomermajorStrategic or Co-development Partner · 1 January 2024Commercial agreement for remote monitoring of high-risk pregnancies using home ultrasound solution. Sheba Medical Center utilizes PulseNmore's solution as part of its obstetrics department in 'Sheba Beyond' virtual hospital, offering medical services to insured individuals across various health funds.
  • Michigan MedicinestrategicStrategic or Co-development Partner · 1 January 2024Clinical trial collaboration examining ability to conduct remote biophysical profile (BPP) test using PulseNmore home ultrasound with guidance of remote clinician. Study focused on potentially reducing clinical visits while maintaining diagnostic accuracy.

Scale indicators15 records

Recent moves10 records

Expansion highlights6 records

PulseNmore competitors and assessment

Company assessment

Direct peers

  • Butterfly Network: Handheld, smartphone-connected ultrasound company offering a single-probe POCUS platform used across multiple clinical specialties. Directly competes with PulseNmore on portable ultrasound form factor and smartphone integration, though Butterfly is not FDA-authorized specifically for home prenatal use.
  • Clarius Mobile Health: Handheld, wireless ultrasound scanners that pair with smartphones/tablets. Closest direct comparator to PulseNmore's smartphone-cradle architecture, particularly in OB-GYN and point-of-care obstetrics use cases.

Broad incumbents

  • GE HealthCare (Vscan): Global ultrasound incumbent with the Vscan Air handheld family. Also a PulseNmore investor/distributor (potential competitor-investor overlap), making it the most strategically important incumbent shaping the home/portable ultrasound category.
  • Philips Lumify: Philips' portable, app-based ultrasound solution for clinicians. A broad incumbent offering overlapping handheld/connected ultrasound capability, though not focused on home prenatal workflows.
  • Mindray: Global medical device manufacturer with a broad portable and point-of-care ultrasound portfolio. Operates as a broad incumbent in the same hardware category as PulseNmore across multiple specialties.
  • Hologic: Major women's health diagnostics and medical device company with ultrasound and reproductive health offerings. Adjacent incumbent providing diagnostic women's health solutions that overlap with prenatal imaging workflows.

Emerging players

  • Exo (Exo Imaging): Developer of handheld ultrasound devices with AI-enabled workflow. Competes with PulseNmore on handheld ultrasound hardware and is pursuing POCUS use cases that overlap with PulseNmore's provider-led model.
  • Babyscripts: Virtual maternity care platform providing remote monitoring for pregnant patients. Comparable to PulseNmore on the connected prenatal care delivery model, though focused on software/BPM rather than imaging hardware.
  • Maven Clinic: Virtual maternity and family care platform serving employers and health plans. Comparable as a virtual prenatal care delivery model that could partner with or compete against PulseNmore for the same telehealth maternity workflows.
  • CooperSurgical: Women's health and fertility device/IVF services company (part of CooperCompanies). Comparable to PulseNmore on the fertility/IVF side, particularly relevant for the Pulsenmore FC follicular monitoring product.

Market position

Weaknesses5 records

Competitive moat5 records

Key risks2 records

Key highlights7 records

Customer concentration

PulseNmore social profiles

Digital presence

PulseNmore compliance and trust

Trust signal

Compliance8 records

PulseNmore financial estimates

Financial estimate

Revenue estimate

Valuation estimate

PulseNmore leadership team

Management profile

Number of profiles

Profiles15 records

PulseNmore subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

PulseNmore funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

PulseNmore M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PulseNmore

What does PulseNmore do?

PulseNmore develops and sells connected home ultrasound hardware devices that pair with a patient's smartphone via a mobile app, enabling expectant mothers to perform guided ultrasound scans at home. The company offers two core products: Pulsenmore ES for prenatal fetal well-being assessment from week 14 and Pulsenmore FC for at-home follicular monitoring in IVF and fertility preservation. Scans are transmitted to a cloud-based clinician dashboard for remote physician interpretation, with a physician-supervised model that includes both app-guided and real-time clinician-guided scanning modes.

Is PulseNmore a public or private company?

PulseNmore is a public company. It is classified as public and is currently operating.

When was PulseNmore founded?

PulseNmore was founded in 2014. It employs 51 to 100 people.

Where is PulseNmore based?

PulseNmore is headquartered in Ramat Gan, Israel, in the Middle East region.

How does PulseNmore make money?

Three revenue lines are on record. Hardware Device Sales are the primary driver. The others are subscription/Service Platform and strategic Investment.

Who are PulseNmore's main competitors?

Direct peers on record are Butterfly Network and Clarius Mobile Health. Broad incumbents are GE HealthCare (Vscan), Philips Lumify, Mindray and Hologic. Emerging players are Exo (Exo Imaging), Babyscripts, Maven Clinic and CooperSurgical.

Does PulseNmore have an API?

No public API is recorded for PulseNmore.

What industry is PulseNmore in?

PulseNmore's product category is Home Prenatal Ultrasound Devices. Its primary akta.pro industry code is HLALAHAC, Pregnancy & Prenatal Care Telehealth (OB tele-visits, prenatal monitoring), with a secondary code of HLACAFAC, Maternal & Neonatal Remote Monitoring Platforms. Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The future of tradingPulsenmore appoints David Woods as chief commercial officerPulsenmore appointed David Woods as chief commercial officer to scale its U.S. commercial operations. Woods previously served as chief commercial officer at Creo Medical and held senior roles at PENTAX Medical, including president and CEO of PENTAX Medical Americas.PR NewswirePulsenmore Expands Its Fertility Platform into the UKPulsenmore completed MHRA registration for its home ultrasound system Pulsenmore FC, enabling UK and Northern Ireland marketing. The UK performed over 100,000 fertility treatment cycles in 2024, with 53,000 IVF procedures. The company plans to expand the system into additional countries.PR NewswirePulsenmore Expands Its Fertility Platform into the UKPulsenmore completed MHRA registration of its home ultrasound system Pulsenmore FC, enabling UK and Northern Ireland marketing. The UK performed over 100,000 fertility treatment cycles in 2024, and the company plans to expand into additional countries.YahooPulsenmore Ltd. Announces Financial Results and Business Highlights for the First Half of 2026Pulsenmore reported H1 2026 revenues of NIS 6.1 million ($2 million), up 53% year-over-year, with an operating loss of NIS 20.8 million ($7 million). The company launched U.S. commercial activities after FDA authorization, signed its first U.S. commercial agreements, and received AI grants totaling NIS 5 million ($1.67 million). Management plans to scale commercial operations and convert early-stage revenue into actual sales.PR NewswirePulsenmore Ltd. Announces Financial Results and Business Highlights for the First Half of 2026Pulsenmore Ltd. reported H1 2026 revenues of NIS 6.1 million ($2 million), up 53% year-over-year, with an operating loss of NIS 20.8 million ($7 million). The company launched U.S. commercial activities after FDA authorization, signed agreements with CFFM and TLC Perinatal, and partnered with Ouma Health. It also received AI grants totaling NIS 5 million ($1.67 million) and plans automated manufacturing in Israel starting 2027.AdvfnPulsenmore Ltd. Announces Financial Results and Business Highlights for the First Half of 2026Pulsenmore reported H1 2026 revenue of NIS 6.1 million ($2 million), up 53% year-over-year, with an operating loss of NIS 20.8 million ($7 million). The company launched U.S. commercial activities after FDA authorization, signed partnerships with Ouma Health and Clalit, and received AI grants totaling NIS 5 million ($1.67 million). It plans automated manufacturing in Israel starting 2027.Medical BuyerAI in healthcare moving from decision support toward more consequentialIsrael's Israel Innovation Authority and Ministry of Health have launched a regulatory sandbox to test autonomous AI systems in healthcare, featuring three companies: Pulsenmore, Cordio Medical, and Simahook. This initiative aims to establish safety standards and accountability frameworks for AI performing defined clinical tasks with increased autonomy. The move is part of a broader global regulatory evolution, paralleled by frameworks in Canada and the EU, to manage the lifecycle risks of evolving medical AI.Stock TitanPulsenmore to Release H1 2026 Results Aug. 31Pulsenmore Ltd. announced that it will release its financial results and business highlights for the first half of 2026 on August 31, 2026. The company will host a webcast at 8:30 am ET to discuss these results and recent progress. This announcement serves as a routine corporate disclosure regarding upcoming earnings.Digital JournalHealthcare AI sandbox points to the next regulatory test: Autonomous medicineIsrael has launched a regulatory sandbox for autonomous medical AI, selecting three health technology companies—Pulsenmore, Cordio Medical, and Simahook—to test their systems in real clinical settings. The initiative aims to establish safety standards and accountability frameworks for AI that performs defined clinical tasks with minimal human oversight, addressing critical gaps in existing regulations.Investing.comPulsenmore expands home ultrasound service to Ichilov hospital By Investing.comPulsenmore announced the integration of its home ultrasound technology at Lis Maternity and Women’s Hospital within Ichilov in Israel. This expansion adds to existing medical centers using the service for pregnancy monitoring, allowing eligible patients to perform scans at home under medical guidance. The company currently operates three models for home ultrasound integration in Israel, including a nationwide service supported by Clalit Health Services.